On demand webinar: Unmatched viral particle analysis in vaccine and gene therapy development
The number of gene therapy applications based on viral vectors are growing and small-scale manufacturing processes are increasingly requiring scale-up to commercial processes.
Numerous challenges must be overcome in scaling-up to full commercial production. Undesired outcomes can be avoided by careful monitoring during development of the process.
In this webinar we will show how MiniTEM can produce powerful data where traditional assays have limitations.
With the introduction of the MiniTEM™ system, transmission electron microscopy has become an accessible method for routine testing in bioprocessing. Through automated image acquisition, particle detection and classification, MiniTEM can provide both high-resolution images and reliable quantitative data in a very short turnaround time.
Key Learning Objectives
How MiniTEM automatically can:
- Screen the viral particle morphology status throughout the process
- Determine sample purity
- Detect aggregates
- Compare the portion of intact versus broken viral particles
- Indicate virus titer
Speaker: Josefina Nilsson, head of EM services & Martin Ryner, Strategic development manager